Clinical Trials Directory

Trials / Completed

CompletedNCT01958411

Correlation Between NAFLD, Epicardial Adipose Tissue and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)

Status
Completed
Phase
Study type
Observational
Enrollment
340 (actual)
Sponsor
Korea University · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Accepted

Summary

* Vascular inflammation is a key factor in both the pathogenesis and outcome of atherosclerosis. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising tool for identifying and quantifying vascular inflammation within atherosclerotic plaques. * Non-alcoholic fatty liver disease (NAFLD) is closely associated with many cardiometabolic risk factors. NAFLD can be detected by measuring liver fat accumulation using computed tomography (CT). * Also epicardial adipose tissue (EAT) volume as determined by computed tomography (CT) is an independent marker of cardiovascular events in the general population. * Therefore, the purpose of this investigators study is to compare the NAFLD severity and EAT volume with FDG uptake measured by PET/CT.

Conditions

Timeline

Start date
2008-12-01
Primary completion
2011-03-01
First posted
2013-10-09
Last updated
2013-10-09

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01958411. Inclusion in this directory is not an endorsement.